Effect of Chelating Agent on Urinary Lead Excretion. Comparison of Oral and Intravenous Administration

Abstract
Di-Na Ca ethylenediaminetetraacetate was given intraven., orally or alternately by both routes to 7 patients with elevated blood Pb and/or urinary Pb excretion. The oral dose was 30 mg./kg. twice daily. Intraven. dosage in adults was 1.0 g. on the 1st day and 2.0 g. for 4 days given in divided doses diluted to 250 ml. with 5% glucose in water. A 5- to 60-fold increment in urinary lead excretion was effected. Intraven. therapy was more effective than oral. No untoward side-reactions were encountered with the dosage indicated.

This publication has 1 reference indexed in Scilit: